Eco-Friendly UPLC–MS/MS Method for Determination of a Fostamatinib Metabolite, Tamatinib, in Plasma: Pharmacokinetic Application in Rats

Eco-Friendly UPLC–MS/MS Method for Determination of a Fostamatinib Metabolite, Tamatinib, in Plasma: Pharmacokinetic Application in Rats

Fostamatinib is a prodrug of the active metabolite tamatinib, which is a spleen tyrosine kinase (Syk) inhibitor used in the treatment of primary chronic adult immune thrombocytopenia and rheumatoid arthritis. A highly sensitive, rapid, reliable, and green method was developed and validated using ult...

Full description

Bibliographic Details
Main Authors:	Essam Ezzeldin, Muzaffar Iqbal, Yousif A. Asiri, Ahmed Y. A. Sayed, Rashad Alsalahi
Format:	Article
Language:	English
Published:	MDPI AG 2021-07-01
Series:	Molecules
Subjects:	fostamatinib tamatinib UPLC–MS/MS pharmacokinetics rat
Online Access:	https://www.mdpi.com/1420-3049/26/15/4663

Similar Items

UPLC-MS/MS analysis of axitinib and pharmacokinetic application in beagle dogs
by: Hengyu Bi, et al.
Published: (2024-10-01)

Eco-Friendly UPLC-MS/MS Quantitation of Delafloxacin in Plasma and Its Application in a Pharmacokinetic Study in Rats
by: Muzaffar Iqbal, et al.
Published: (2021-09-01)

Eco-Friendly, Simple, Fast, and Sensitive UPLC-MS/MS Method for Determination of Pexidartinib in Plasma and Its Application to Metabolic Stability
by: Essam Ezzeldin, et al.
Published: (2022-01-01)

Development of an UPLC-MS/MS method for quantitative analysis of abexinostat levels in rat plasma and application of pharmacokinetics
by: Yige Yu, et al.
Published: (2024-02-01)

An Ultra-Performance Liquid Chromatography–Tandem Mass Spectrometry (UPLC–MS/MS) Method for Qualifying DAPB in Rat Plasma and Application to Pharmacokinetic Studies
by: Bei Qin, et al.
Published: (2024-01-01)

Determination of doxorubicin in plasma and tissues of mice by UPLC-MS/MS and its application to pharmacokinetic study
by: Zhilin Jin, et al.
Published: (2024-08-01)

Pharmacokinetics, Bioavailability, and Tissue Distribution of the Kirsten Rat Sarcoma Inhibitor Adagrasib in Rats Using UPLC-MS/MS
by: Lei P, et al.
Published: (2024-01-01)

Herb-drug interactions of silybinin and cilofexor in beagle dogs based on pharmacokinetics by UPLC-MS/MS
by: Xinyi Wei, et al.
Published: (2024-02-01)

The Pharmacokinetic Effect of Itraconazole and Voriconazole on Ripretinib in Beagle Dogs by UPLC-MS/MS Technique [Corrigendum]
by: Wang H, et al.
Published: (2023-11-01)

Development of UPLC-MS/MS Method to Study the Pharmacokinetic Interaction between Sorafenib and Dapagliflozin in Rats
by: Xueru He, et al.
Published: (2022-09-01)

Simultaneous measurement of COVID-19 treatment drugs (nirmatrelvir and ritonavir) in rat plasma by UPLC-MS/MS and its application to a pharmacokinetic study
by: Chen-Jian Zhou, et al.
Published: (2024-06-01)

A Hydrophilic Interaction Liquid Chromatography–Tandem Mass Spectrometry Quantitative Method for Determination of Baricitinib in Plasma, and Its Application in a Pharmacokinetic Study in Rats
by: Essam Ezzeldin, et al.
Published: (2020-03-01)

Effects of <i>Catha edulis</i> (Khat) on the Pharmacokinetics of Metformin in Diabetic Rats Using UPLC/MS/MS Analysis and Its Impact on Hepatic CYP450 Enzymes
by: Ali S. Alqahtani, et al.
Published: (2023-08-01)

A pharmacokinetic study on twenty-one compounds in rat plasma by integrating UPLC-QQQ-MS/MS with GC-MS after oral administration of Suxiao Jiuxin pill
by: Ye Shang, et al.
Published: (2024-01-01)

Measurement of tepotinib by UPLC‒MS/MS and its interaction with naringenin in rats
by: Zhe Chen, et al.
Published: (2024-11-01)

Ecofriendly, Simple, Fast and Sensitive UPLC-MS/MS Method for Determination of Erdafitinib, a Novel Tyrosine Kinase Inhibitor, in Plasma and Its Application to Metabolic Stability
by: Essam A. Ali, et al.
Published: (2022-08-01)

Green Bio-Analytical Study of Gabapentin in Human Plasma Coupled with Pharmacokinetic and Bioequivalence Assessment Using UPLC-MS/MS
by: Rehab Moussa Tony, et al.
Published: (2023-04-01)

Development and Validation a UPLC-MS/MS Method for Quantification of Pentoxifylline in Beagle Plasma: Application for Pharmacokinetic Study of Food Effect
by: Xu Y, et al.
Published: (2023-11-01)

Determination of Lekethromycin, a Novel Macrolide Lactone, in Rat Plasma by UPLC-MS/MS and Its Application to a Pharmacokinetic Study
by: Hongzhi Xiao, et al.
Published: (2020-10-01)

A Simple UPLC/MS-MS Method for Simultaneous Determination of Lenvatinib and Telmisartan in Rat Plasma, and Its Application to Pharmacokinetic Drug-Drug Interaction Study
by: Yanjun Cui, et al.
Published: (2022-02-01)

Development of a UHPLC-MS/MS Method for the Determination of Moxidectin in Rat Plasma and Its Application in Pharmacokinetics
by: Hongjuan Zhang, et al.
Published: (2024-10-01)

Quantitative investigation of drug-drug interaction between bergenin and vilazodone in rats through UPLC-MS/MS assay
by: Mengming Xia, et al.
Published: (2024-05-01)

Development of a UPLC-MS/MS method for quantifying KPT-335 (Verdinexor) in feline plasma for a study of PK
by: Yuxin Yang, et al.
Published: (2024-07-01)

Development of a UPLC-MS/MS method for the determination of sulfatinib and its no interaction with myricetin in rats
by: Dongxin Chen, et al.
Published: (2024-12-01)

UPLC-MS/MS Method for Givinostat in Rat Plasma: Development, Validation, in vivo Pharmacokinetics Study and in vitro Metabolic Stability Research
by: Zhan R, et al.
Published: (2025-01-01)

Determination of the extremolyte ectoine in plasma and a pharmacokinetic study in rats by a validated and BAGI-evaluated UPLC-MS/MS method
by: Mahmoud Rabee, et al.
Published: (2024-10-01)

Corrigendum: Development of a UPLC-MS/MS method for quantifying KPT-335 (Verdinexor) in feline plasma for a study of PK
by: Yuxin Yang, et al.
Published: (2024-09-01)

Application of a Quality by Design Approach to Develop a Simple, Fast, and Sensitive UPLC-MS/MS Method for Quantification of Safinamide, an Antiparkinson’s Drug, in Plasma
by: Essam A. Ali, et al.
Published: (2023-08-01)

Simultaneous determination of multiple components in rat plasma by UPLC-MS/MS for pharmacokinetic studies after oral administration of Pogostemon cablin extract
by: Yameng Zhu, et al.
Published: (2024-05-01)

Development and Validation of an Ecofriendly, Rapid, Simple and Sensitive UPLC-MS/MS Method for Entrectinib Quantification in Plasma for Therapeutic Drug Monitoring
by: Essam A. Ali, et al.
Published: (2023-09-01)

Quantitative Determination of 5-Aminoisoquinoline, a PARP-1 Inhibitor by UPLC-MS/MS: In Silico ADME Profile and In Vitro Metabolic Stability Study
by: Muzaffar Iqbal, et al.
Published: (2022-06-01)

UPLC-MS/MS determination of 71 neuropsychotropic drugs in human serum
by: Weifeng Jin, et al.
Published: (2024-06-01)

Determination of Aflatoxins in Grains by QuEChERS-UPLC-MS/MS
by: WU Qin-yan, et al.
Published: (2024-03-01)

A Validated UPLC-MS/MS Method for Rapid Quantification of Umifenovir in Plasma Samples and Its Greenness Assessment
by: Muzaffar Iqbal, et al.
Published: (2023-06-01)

Development and validation of UPLC-MS/MS method for icariin and its metabolites in mouse urine
by: Na Li, et al.
Published: (2024-06-01)

Qualitative and Quantitative Analysis of Phytochemicals in Sayeok-Tang via UPLC-Q-Orbitrap-MS and UPLC-TQ-MS/MS
by: Yu Jin Kim, et al.
Published: (2024-08-01)

Pharmacokinetics Study of Jin-Gu-Lian Prescription and Its Core Drug Pair (<i>Sargentodoxa cuneata</i> (Oliv.) Rehd. et W and <i>Alangium chinense</i> (Lour.) Harms) by UPLC-MS/MS
by: Lin Zheng, et al.
Published: (2022-06-01)

UPLC-MS/MS Based Identification and Quantification of a Novel Dual Orexin Receptor Antagonist in Plasma Samples by Validated SWGTOX Guidelines
by: Muzaffar Iqbal, et al.
Published: (2023-01-01)

Simultaneous Determination of Multiple Acid-Suppressing Drugs by UPLC-MS/MS Method and Application for Pharmacokinetics Study
by: Li X, et al.
Published: (2025-02-01)

Quantitative Analysis of Eight Compounds in Traditional Korean Medicine, Gongjindan Using HPLC, UPLC–MS/MS, and GC–MS/MS Systems
by: Chang-Seob Seo, et al.
Published: (2023-03-01)